This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Yangtze River Pharmaceutical Group Co., Ltd.. Active years: 2021.
Company Filing History:
2 out of 20 
2 out of 26 Years Active: 2021
Title: Innovator Changjiang Qiao: A Pioneer in Pharmaceutical Innovations
Introduction
Changjiang Qiao is a notable inventor based in Shanghai, China. He is recognized for his contributions to the field of medicinal chemistry, holding two patents that have implications in pharmaceutical applications. His work demonstrates a substantial commitment to advancing drug development processes.
Latest Patents
Changjiang Qiao’s latest patents highlight innovative chemical compounds with significant medical potential. The first patent involves an Aniline-substituted 1,2-dihydropyrrol[3,4-C]pyridin/pyrimidin-3-one derivative. This invention focuses on compounds that are substituted by N-(3-aminophenyl)acrylamide, detailing both their preparation method and pharmaceutical applications. Importantly, the patent specifies the chemical structures involved, including the definition of each substituent.
His second patent covers 4,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivatives. Similar to his first patent, this one outlines the preparation and medicinal uses of these novel compounds. The intricate details of the compounds, including their formulas and potential therapeutic applications, reflect Qiao’s expertise in innovative drug design.
Career Highlights
Throughout his career, Changjiang Qiao has contributed significantly to the pharmaceutical industry. He has worked with renowned companies such as Yangtze River Pharmaceutical Group Co., Ltd. and Shanghai Haiyan Pharmaceutical Technology Co., Ltd. These experiences have provided him with a strong foundation in both research and practical applications of his inventions.
Collaborations
During his career, Qiao has collaborated with various specialists in the field, including notable coworkers Shuchun Guo and Fusheng Zhou. These partnerships have played a pivotal role in the advancement of his research and the successful development of his patented compounds.
Conclusion
Changjiang Qiao exemplifies the spirit of innovation in the pharmaceutical sector. His patented inventions signify important advancements that could reshape therapeutic practices. As he continues to push the boundaries of medicinal research, he remains a vital figure in the pursuit of new and effective medical treatments.